Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these ne...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pharmaceutics
Huvudupphovsmän: Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7076491/
https://ncbi.nlm.nih.gov/pubmed/32053962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12020146
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk